Prognostic Value of DTI and fMRI of Cervical Myelopathy (CSM)
Prognostic Value of Diffusion Tensor Imaging and fMRI in Surgical Management of Cervical Myelopathy
Sponsor: The University of Hong Kong
A observational or N/A phase clinical study on Cervical Myelopathy, this trial is completed. The trial is conducted by The University of Hong Kong and has accumulated 8 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jun 2023 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Mar 2022 — Jun 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Recruiting
-
May 2019 — Feb 2020 [monthly]
Recruiting
-
Nov 2018 — May 2019 [monthly]
Recruiting
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- The University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .